• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Vascular Stents Market 2012-2016 Product Image

Global Vascular Stents Market 2012-2016

  • ID: 2526543
  • April 2013
  • Region: Global
  • 45 pages
  • TechNavio

FEATURED COMPANIES

  • Abbott Laboratories
  • and Cordis Corp
  • Blue Medical
  • Cook Medical Inc.
  • Goodman Co. Ltd.
  • MIV Therapeutics Inc.
  • MORE

TechNavio's analysts forecast the Global Vascular Stents Market to grow at a CAGR of 8.21 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular disease. The Global Vascular Stents Market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, availability of alternative therapies could pose a challenge to the growth of this market.

TechNavio's report, the Global Vascular Stents market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Vascular Stents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space Abbott Laboratories, Medtronic Inc., Boston Scientific Corp., and Cordis Corp.

Other vendors mentioned in the report are MicroPort Scientific Corp., Cook Medical, Biosensors International Ltd., and B. Braun Melsungen AG, Allvivo Vascular Inc., Arterial Remodeling Technologies, READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • and Cordis Corp
  • Blue Medical
  • Cook Medical Inc.
  • Goodman Co. Ltd.
  • MIV Therapeutics Inc.
  • MORE

1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Scope of the Report
Market Overview
Product Offerings
5. Market Landscape
5.1. Market Size and Forecast
5.2. Market Segmentation by Category
5.3. Market Segmentation by Delivery Platform
5.4. Global Coronary Stents Market
Market Size and Forecast
Geographical Segmentation
Market Segmentation
5.5. Global Drug Eluting Stents Market
Market Size and Forecast
5.6. Global Bare Metal Stents Market
Market Size and Forecast
5.7. Global Peripheral Vascular Stents Market
Market Size and Forecast
5.8. Global Carotid Artery Stents Market
Market Size and Forecast
5.9. Five Forces Analysis
6. Geographical Segmentation
7. Key Leading Countries
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Information
15.1.3. SWOT Analysis
15.2. Medtronic Inc.
15.2.1. Business Overview
15.2.2. Business Segmentation
15.2.3. Key Information
15.2.4. SWOT Analysis
15.3. Boston Scientific Corp.
15.3.1. Business Overview
15.3.2. Key Information
15.3.3. SWOT Analysis
15.4. Cordis Corp.
15.4.1. Business Overview
15.4.2. Business Segmentation
15.4.3. Key Information
15.4.4. SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Vascular Stents Market 2012-2016 (US$ billion)
Exhibit 2: Global Vascular Stents Market by Category Segmentation
Exhibit 3: Global Vascular Stents Market by Category Segmentation 2012
Exhibit 4: Global Vascular Stents Market Segmentation by Delivery Platform
Exhibit 5: Global Coronary Stents Market 2012-2016 (US$ billion)
Exhibit 6: Global Coronary Stents Market by Geographical Segmentation2012
Exhibit 7: Global Coronary Stents Market Segmentation
Exhibit 8: Global Coronary Stents Market by Product Segmentation 2012
Exhibit 9: Global Coronary Stents Market by Product Segmentation 2016
Exhibit 10: Global Drug Eluting Stents Market 2012-2016 (US$ billion)
Exhibit 11: Global Bare Metal Stents Market 2012-2016 (US$ billion)
Exhibit 12: Global Peripheral Vascular Stents Market 2012-2016 (US$ billion)
Exhibit 13: Global Carotid Artery Stents Market 2012-2016 (US$ billion)
Exhibit 14: Global Vascular Stents Market by Geographical Segmentation 2012
Exhibit 15: Global Vascular Stents Market by Vendor Segmentation 2012
Exhibit 16: Business Segmentation of Abbott Laboratories
Exhibit 17: Business Segmentation of Medtronic Inc.
Exhibit 18: Business Segmentation of Boston Scientific Corp.
Exhibit 19: Business Segmentation of Cordis Corp.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • and Cordis Corp
  • Blue Medical
  • Cook Medical Inc.
  • Goodman Co. Ltd.
  • MIV Therapeutics Inc.
  • MORE

TechNavio Announces the Publication of its Research Report - Global Vascular Stents Market 2012-2016

TechNavio recognizes the following companies as the key players in the Global Vascular Stents Market: Abbott Laboratories, Medtronic Inc., Boston Scientific Corp., and Cordis Corp.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''There is an increasing demand for minimally invasive surgery among the rapidly increasing aging population across the world, and this is expected to propel the growth of the Global Vascular Stents market. Minimally invasive endovascular procedures are performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantage of these procedures over conventional surgical methods is the short recovery time, short length of the scars resulting in less physical trauma, low risk of infection, minimized bleeding, low cost, and shorter hospital stays.''

According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. Unhealthy diet and lack of physical activity are the major factors leading to an increase in the number of people prone to CVD.

Further, the report states that one of the major challenges in the market is the availability of alternative therapies such as heart bypass surgery, cell transplantation, and drugs. These therapies are known to have better survival rates than stenting.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are MicroPort Scientific Corp., Cook Medical Inc., Biosensors International Ltd., B. Braun Melsungen AG, Allvivo Vascular Inc., Arterial Remodeling Technologies, Biocompatibles Ltd., Biotronik KG, Devax Inc., Endovasc Inc., Goodman Co. Ltd., InnoCore Technologies BV, MIV Therapeutics Inc., Reva Medical Inc., Stentys SA, SurModics Inc., Translumina GmbH, X-Cell Medical Inc., and Xtent Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown

- Abbott Laboratories
- Medtronic Inc.
- Boston Scientific Corp.
- and Cordis Corp
- MicroPort Scientific Corp.
- Cook Medical
- Biosensors International Ltd.
- and B. Braun Melsungen AG
- Allvivo Vascular Inc.
- Arterial Remodeling Technologies
- Biocompatibles Ltd.
- Biotronik KG
- Blue Medical
- Cook Medical Inc.
- Devax Inc.
- Endovasc Inc.
- Goodman Co. Ltd.
- InnoCore Technologies BV
- MIV Therapeutics Inc.
- Reva Medical Inc.
- Stentys SA
- SurModics Inc.
- Translumina GmbH
- X-Cell Medical Inc.
- Xtent Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos